Evaluating treatments in health care: The instability of a one-legged stool

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Kaplan, Bonnie J ^a   Giesbrecht, Gerald ^a   Shannon, Scott ^b   McLeod, Kevin ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; METHODOLOGY; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DECISION MAKING; DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 79955778081     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-65     Document Type: Article

References (26)

1. Balancing health care evidence and art to meet clinical needs: policymakers' perspectives. LE Parker MJ Ritchie JE Kirchner RR Owen, J Eval Clin Pract 2009 15 970 975 10.1111/j.1365-2753.2009.01209.x 20367694
2. The randomized controlled trial: an excellent design, but can it address the big questions in neurodisability? P Rosenbaum, Dev Med Child Neurol 2010 52 111 20412250
3. Disseminating innovations in health care. DM Berwick, JAMA 2003 289 1969 1975 10.1001/jama.289.15.1969 12697800 (Pubitemid 37430229)
4. Principles of Medical Statistics. I. The aim of the statistical method. AB Hill, The Lancet 1937 41 43
5. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948 2 769 782 Anonymous 18890300
6. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group, JAMA 1992 268 2420 2425 1404801
7. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997. J Kulynych, Food Drug Law J 1999 54 127 149 11758555 (Pubitemid 29181673)
8. A Clinician's Guide to Statistics and Epidemiology in Mental Health: Measuring Truth and Uncertainty. SN Ghaemi, Cambridge University Press 2009
9. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. H Walach T Falkenberg V Fonnebo G Lewith WB Jonas, BMC Med Res Methodol 2006 6 29 10.1186/1471-2288-6-29 16796762
10. Randomized, controlled trials, observational studies, and the hierarchy of research designs. J Concato N Shah RI Horwitz, N Engl J Med 2000 342 1887 1892 10.1056/NEJM200006223422507 10861325 (Pubitemid 30419054)
11. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). RC Kessler P Berglund O Demler R Jin D Koretz KR Merikangas AJ Rush EE Walters PS Wang National Comorbidity Survey Replication, JAMA 2003 289 3095 3105 10.1001/jama.289.23.3095 12813115 (Pubitemid 37432885)
12. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. SR Wisniewski AJ Rush AA Nierenberg BN Gaynes D Warden JF Luther PJ McGrath PW Lavori ME Thase M Fava MH Trivedi, Am J Psychiatry 2009 166 599 607 10.1176/appi.ajp.2008.08071027 19339358
13. Personalizing medicine: a systems biology perspective. TS Deisboeck, Mol Syst Biol 2009 5 249 19293829
14. External validity of randomised controlled trials: "to whom do the results of this trial apply?". PM Rothwell, Lancet 2005 365 82 93 10.1016/S0140-6736(04)17670-8 15639683 (Pubitemid 40082150)
15. The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. MW Lipsey DB Wilson, Am Psychol 1993 48 1181 1209 8297057
16. Pharmaceutical Industry Profile 2010. Pharmaceutical Research and Manufacturers of America, 2010
17. Guinea-pigging. C Elliott, Minn Med 2008 91 32 36 19902619
18. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living? C Elliott, New Yorker 2008 36 41
19. The professional guinea pig: Big Pharma and the risky world of human subjects. R Abadie, Duke University Press 2010
20. Selective publication of antidepressant trials and its influence on apparent efficacy. EH Turner AM Matthews E Linardatos RA Tell R Rosenthal, N Engl J Med 2008 358 252 260 10.1056/NEJMsa065779 18199864
21. Specificity profile of paroxetine in major depressive disorder: Meta-regression of double-blind, randomized clinical trials. A Serretti S Gibiino A Drago, J Affect Disord 2010
22. The Environment and Disease: Association or Causation? AB Hill, Proc R Soc Med 1965 58 295 300 14283879
23. Modern epidemiology. KJ Rothman S Greenland, Philadelphia: Lippinocott-Raven 2 1998
24. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. I Kirsch BJ Deacon TB Huedo-Medina A Scoboria TJ Moore BT Johnson, PLoS Med 2008 5 45 10.1371/journal.pmed.0050045 18303940
25. The Structure of Scientific Revolutions. TS Kuhn, Chicago: University of Chicago Press 1962
26. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. GC Smith JP Pell, BMJ 2003 327 1459 1461 10.1136/bmj.327.7429.1459 14684649 (Pubitemid 38045824)